1. |
Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Use of Systemic Corticosteroids for Reasons Other than Asthma in Subjects with Asthma. Respiration, 101: 109-115, 2022. |
2. |
Fukuda N, Horita N, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis. Thorac Cancer, 13: 84-94, 2022. |
3. |
Matsumoto H, Kobayashi N, Somekawa K, Fukuda N, Kaneko A, Kamimaki C, Kubo S, Tanaka K, Tagami Y, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Koizumi H, Miura K, Miyazawa N, Kaneko T: Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial. Thorac Cancer, 13: 228-235, 2022. |
4. |
Hara Y, Oshima Y, Tagami Y, Aoki A, Fujii H, Izawa A, Seki K, Kanai A, Yabe A, Watanabe K, Horita N, Kobayashi N, Kaneko T: Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019. Respir Med Case Rep, 36:101615, 2022. |
5. |
Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic. Respirology, 27: 175-176, 2022. |
6. |
Chen H, Katakura S, Horita N, Namkoong H, Kato I, Hara Y, Kobayashi N, Fujii S, Kaneko T: Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Ther Adv Med Oncol, 14: 17588359211065152, 2022. |
7. |
Somekawa K, Horita N, Kaneko A, Tagami Y, Fukuda N, Matsumoto H, Namkoong H, Fujiwara Y, Minegishi K, Fukumoto T, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by nivolumab and ipilimumab combination regimens. Ther Adv Med Oncol, 14: 17588359211058393, 2022. |
8. |
Adachi S, Oshikata C, Kaneko T, Tsurikisawa N: Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi. Allergy Asthma Clin Immunol, 18: 18, 2022. |
9. |
Oshikata C, Watanabe M, Hashimoto K, Yamazaki A, Kobayashi N, Konuma R, Ishida M, Kobayashi S, Shimada T, Kaneko T, Kamata Y, Kuriyama S, Kure S, Yanai M, Tsurikisawa N: Mite allergen avoidance decreases allergic symptoms in children in Ishinomaki city of Japan after natural disasters. Allergol Immunopathol (Madr), 50: 23-32, 2022. |
10. |
Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N: Behçet's disease and activities of daily living. Rheumatology(Oxford), 61: 1133-1140, 2022. |
11. |
Teranishi S, Sugimoto C, Nagayama H, Segawa W, Miyasaka A, Hiro S, Maeda C, Tamura H, Masumoto N, Nagahara Y, Hirama N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma. Cancer Diagn Progn, 2: 253-257, 2022. |
12. |
Doshita K, Kenmotsu H, Omori S, Tabuchi Y, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Miyawaki T, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T: Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis. Invest New Drugs, 40: 411-419, 2022. |
13. |
Oshikata C, Zhu Y, Tanaka R, Kurihara Y, Kaneko T, Tsurikisawa N: Anaphylaxis caused by cross-reactivity of furocoumarins in lemon with orchardgrass. Ann Allergy Asthma Immunol , 128: 721-722, 2022. |
14. |
Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Declined Mortality Due to Seasonal Influenza in Japan During the Coronavirus Disease 2019 Pandemic. Clin Infect Dis, 74: 2081, 2022. |
15. |
Mikami N, Takeda A, Hashimoto A, Takeda T, Kimura Y, Oku Y, Aoki Y, Eriguchi T, Tsurugai Y, Saeki N, Enomoto T, Kuribayashi H, Masuda M, Kaneko T: CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy. Clin Lung Cancer, 23: 428-437, 2022. |
16. |
Oshikata C, Watanabe M, Hashimoto K, Yamazaki A, Kobayashi N, Konuma R, Ishida M, Kobayashi S, Shimada T, Kaneko T, Kamata Y, Kuriyama S, Kure S, Yanai M, Tsurikisawa N: Effects of mite allergen avoidance in children in two distant towns in Japan. La Revue Française d'Allergologie, 62:661-669, 2022. |
17. |
Kata Y, Hara Y, Tagami Y, Yabe A, Murohashi K, Nagasawa R, Nakashima K, Fujii H, Saigusa Y, Shiida M, Watanabe K, Horita N, Kobayashi N, Kaneko T: Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias. Sci Rep, 12: 12935, 2022. |
18. |
Hara Y, Tsukiji J, Yabe A, Onishi Y, Hirose H, Yamamoto M, Kudo M, Kaneko T, Ebina T: Heme oxygenase-1 as an important predictor of the severity of COVID-19. PLoS One, 17: e0273500, 2022. |
19. |
Chen H, Hara Y, Horita N, Saigusa Y, Hirai Y, Kaneko T: Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study. BMJ Open, 12: e051307, 2022. |
20. |
Teranishi S, Sugimoto C, Nagaoka S, Nagayama H, Segawa W, Miyasaka A, Hiro S, Kajita Y, Maeda C, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line Osimertinib. Thorac Cancer, 13: 2741-2750, 2022. |
21. |
Fujii H, Nagakura H, Kobayashi N, Kubo S, Tanaka K, Watanabe K, Horita N, Hara Y, Nishikawa M, Miura K, Koizumi H, Ito Y, Tsubakihara M, Miyazawa N, Kudo M, Shinkai M, Kaneko T: Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study. BMC Cancer, 22: 1035, 2022. |
22. |
Kato A, Horita N, Namkoong H, Nomura E, Masuhara N, Kaneko T, Mizuki N, Takeuchi M: Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes. Sci Rep, 12: 17416, 2022. |
23. |
Masumoto N, Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Elderly sarcoidosis in Japan. J Int Med Res, 50: 3000605221142705, 2022. |
24. |
Otsu Y, Kata Y, Takayasu H, Inoue S, Kaneko T: Entrectinib-Induced Heart Failure in a Patient With Metastatic Lung Adenocarcinoma: A Case Report. Cureus, 14: e32174, 2022. |
25. |
Doshita K, Tabuchi Y, Kenmotsu H, Omori S, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T: Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy. Adv Radiat Oncol, 8: 101129, 2022. |
26. |
高橋浩一郎, 小林信明, 金子 猛: 呼吸器内科医の大学院進学とキャリア形成について, 日本呼吸器学会誌, 11: 128, 2022. |
27. |
住友みどり, 山崎悦子, 友山瑛人, 佐野加代子, 松永 智, 佐藤泰之, 川崎理加, 満田年宏, 金子 猛: 横浜市立大学附属病院における過去18年間の分離菌の抗菌薬感受性の検討. 横浜医学, 73: 517-527, 2022. |
28. |
堀田信之: 正岡/正岡古賀II/III病期胸腺腫の完全切除に対する術後放射線治療. 横浜医学, 73: 553-560, 2022. |